Yasmin Safety Labeling Change May Depend On FDA Epidemiologic Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Results from the FDA-funded retrospective epidemiologic cohort study of more than 800,000 women are expected later this summer.